HomeCompareLUMO vs PLD

LUMO vs PLD: Dividend Comparison 2026

LUMO yields 46.08% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.18M in total portfolio value· pulled ahead in Year 8
10 years
LUMO
LUMO
● Live price
46.08%
Share price
$4.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$321.2K
Annual income
$60,965.20
Full LUMO calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — LUMO vs PLD

📍 PLD pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLUMOPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LUMO + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LUMO pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LUMO
Annual income on $10K today (after 15% tax)
$3,917.05/yr
After 10yr DRIP, annual income (after tax)
$51,820.42/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,416,150.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LUMO + PLD for your $10,000?

LUMO: 50%PLD: 50%
100% PLD50/50100% LUMO
Portfolio after 10yr
$3.41M
Annual income
$2,658,700.69/yr
Blended yield
77.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

LUMO
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Price Target
$16.50
+280.2% upside vs current
Range: $7.00 — $26.00
Altman Z
-19.2
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LUMO buys
0
PLD buys
0
No recent congressional trades found for LUMO or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLUMOPLD
Forward yield46.08%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$321.2K$6.50M
Annual income after 10y$60,965.20$5,256,436.18
Total dividends collected$251.2K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$16.50$136.00

Year-by-year: LUMO vs PLD ($10,000, DRIP)

YearLUMO PortfolioLUMO Income/yrPLD PortfolioPLD Income/yrGap
1$15,308$4,608.29$11,255$555.24+$4.1KLUMO
2$22,973$6,593.00$13,062$1,018.59+$9.9KLUMO
3$33,828$9,246.73$15,903$1,926.67+$17.9KLUMO
4$48,921$12,725.11$20,839$3,823.32+$28.1KLUMO
5$69,544$17,198.81$30,464$8,166.08+$39.1KLUMO
6$97,262$22,849.74$52,054$19,457.30+$45.2KLUMO
7$133,936$29,866.21$109,886$54,188.93+$24.1KLUMO
8← crossover$181,749$38,437.25$304,030$186,451.18$122.3KPLD
9$243,218$48,746.39$1,166,125$840,813.32$922.9KPLD
10$321,208$60,965.20$6,504,190$5,256,436.18$6.18MPLD

LUMO vs PLD: Complete Analysis 2026

LUMOStock

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

Full LUMO Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this LUMO vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LUMO vs SCHDLUMO vs JEPILUMO vs OLUMO vs KOLUMO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.